Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current State of Liver-Directed Therapies and Combinatory Approaches with Systemic Therapy in Hepatocellular Carcinoma (HCC)
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 8, Pages 1085
Publisher
MDPI AG
Online
2019-07-31
DOI
10.3390/cancers11081085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Goals and targets for personalized therapy for HCC
- (2019) Thomas Couri et al. Hepatology International
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Protons versus Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival
- (2019) Nina N. Sanford et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma
- (2019) Adriaan A. Beek et al. INTERNATIONAL JOURNAL OF CANCER
- Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas
- (2019) R. Yeung et al. CLINICAL ONCOLOGY
- Inhibiting Glutamine-Dependent mTORC1 Activation Ameliorates Liver Cancers Driven by β-Catenin Mutations
- (2019) Adeola O. Adebayo Michael et al. Cell Metabolism
- Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
- (2019) Liang-Cheng Chen et al. BMC CANCER
- Is hepatectomy safe following Yttrium-90 therapy? A multi-institutional international experience
- (2019) Laleh G. Melstrom et al. HPB
- Positive Immuno-Modulation Following Radiofrequency Assisted Liver Resection in Hepatocellular Carcinoma
- (2019) Kai Wen Huang et al. Journal of Clinical Medicine
- Wnt/β-Catenin Signaling in Liver Cancers
- (2019) Wenhui Wang et al. Cancers
- Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma
- (2018) Tim A. Labeur et al. ACTA ONCOLOGICA
- Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma
- (2018) Brian C. Baumann et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- The role of external beam radiotherapy in the treatment of hepatocellular cancer
- (2018) Fumiko Chino et al. CANCER
- Y-90 Radioembolization Combined with a PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
- (2018) Eric Wehrenberg-Klee et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Transarterial chemoembolization for hepatocellular carcinoma
- (2018) Mark op den Winkel et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
- (2018) Valerie Chew et al. GUT
- Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
- (2018) Riad Salem et al. HEPATOLOGY
- Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma
- (2018) Eli Sapir et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Low Rates of Retention Into Hepatocellular Carcinoma (HCC) Surveillance Program After Initial HCC Screening
- (2018) Ann Robinson et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
- (2018) Pierce K.H. Chow et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
- (2018) Andrew X Zhu et al. LANCET ONCOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification
- (2018) Rita Golfieri et al. Liver Cancer
- Unknown
- (2018) Experimental and Clinical Transplantation
- Proposal of Primary Endpoints for TACE Combination Trials with Systemic Therapy: Lessons Learned from 5 Negative Trials and the Positive TACTICS Trial
- (2018) Masatoshi Kudo Liver Cancer
- Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
- (2018) Yang Yi et al. Cancer Biology & Medicine
- Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
- (2018) Hyung-Don Kim et al. GASTROENTEROLOGY
- Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization
- (2017) Ahmed Gabr et al. EUROPEAN JOURNAL OF RADIOLOGY
- Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
- (2017) Gonzalo Sapisochin et al. JOURNAL OF HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial
- (2017) Valérie Vilgrain et al. LANCET ONCOLOGY
- Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
- (2017) Konstantinos Katsanos et al. PLoS One
- Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series
- (2017) Olivier Sutter et al. RADIOLOGY
- Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort
- (2017) Xavier Adhoute et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis
- (2017) Wen Luo et al. World Journal of Surgical Oncology
- Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study
- (2017) Ji Hae Nahm et al. Oncotarget
- Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation
- (2017) Giovanni Battista Levi Sandri et al. HEPATOBILIARY SURGERY AND NUTRITION
- Does neoadjuvant doxorubicin drug-eluting bead transarterial chemoembolization improve survival in patients undergoing liver transplant for hepatocellular carcinoma?
- (2017) Dimitri Dorcaratto et al. Diagnostic and Interventional Radiology
- Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
- (2016) Joseph Ralph Kallini et al. ADVANCES IN THERAPY
- Efficacy, Safety, and Potential Biomarkers of Sunitinib and Transarterial Chemoembolization (TACE) Combination in Advanced Hepatocellular Carcinoma (HCC)
- (2016) Venkata K. Pokuri et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Different expression of VEGF and EGFL7 in human hepatocellular carcinoma
- (2016) Luisa Campagnolo et al. DIGESTIVE AND LIVER DISEASE
- Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
- (2016) Riad Salem et al. GASTROENTEROLOGY
- Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
- (2016) Riccardo Lencioni et al. JOURNAL OF HEPATOLOGY
- 90Y radiation lobectomy: Outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes
- (2016) Robert J. Lewandowski et al. JOURNAL OF SURGICAL ONCOLOGY
- World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015
- (2016) Shelley McGuire Advances in Nutrition
- List and Liver Transplant Survival According to Waiting Time in Patients With Hepatocellular Carcinoma
- (2015) P. R. Salvalaggio et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
- (2015) Roman Kloeckner et al. BMC CANCER
- Favorable Survival Time Provided with Radioembolization in Hepatocellular Carcinoma Patients with and Without Portal Vein Thrombosis
- (2015) Zeynep Gozde Ozkan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
- (2015) Chunping Wang et al. HEPATOLOGY
- Radiofrequency ablationversuslaser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
- (2015) Giovan Giuseppe Di Costanzo et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
- (2015) Frank T. Kolligs et al. LIVER INTERNATIONAL
- Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement
- (2015) Roderich E. Schwarz et al. HPB
- Randomized Comparison of Selective Internal Radiotherapy (SIRT) Versus Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) for the Treatment of Hepatocellular Carcinoma
- (2014) Michael B. Pitton et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Emerging trends in hepatocellular carcinoma incidence and mortality
- (2014) Basile Njei et al. HEPATOLOGY
- How to STATE suitability and START transarterial chemoembolization in patients with intermediate stage hepatocellular carcinoma
- (2014) Florian Hucke et al. JOURNAL OF HEPATOLOGY
- Prognostic role of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma undergoing liver transplantation
- (2014) Wei Zhang et al. LIVER TRANSPLANTATION
- Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience
- (2014) Ashraf Abdelaziz et al. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
- Conventional TACE and Drug-Eluting Bead TACE as Locoregional Therapy Before Orthotopic Liver Transplantation
- (2014) Catherine T. Frenette et al. TRANSPLANTATION
- Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review
- (2014) Zhi-Bo Xie et al. TUMOR BIOLOGY
- Molecular targeting agents associated with transarterial chemoembolization or radiofrequency ablation in hepatocarcinoma treatment
- (2014) Girolamo Ranieri WORLD JOURNAL OF GASTROENTEROLOGY
- A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
- (2013) L. Kadalayil et al. ANNALS OF ONCOLOGY
- A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
- (2013) T Meyer et al. BRITISH JOURNAL OF CANCER
- Transarterial embolization as neo-adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
- (2013) Emmanuel Tsochatzis et al. LIVER INTERNATIONAL
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
- (2011) Masatoshi Kudo et al. EUROPEAN JOURNAL OF CANCER
- Clinical and Prognostic Implications of Plasma Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Patients With Hepatocellular Carcinoma
- (2011) Ahmed O. Kaseb et al. JOURNAL OF CLINICAL ONCOLOGY
- Conventional versus Doxorubicin-eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
- (2011) Rodolfo Sacco et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
- (2010) Gang Niu et al. CURRENT DRUG TARGETS
- Radiation Segmentectomy: A Novel Approach to Increase Safety and Efficacy of Radioembolization
- (2010) Ahsun Riaz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
- (2009) R. J. Lewandowski et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 Radioembolization
- (2009) Ron C. Gaba et al. ANNALS OF SURGICAL ONCOLOGY
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
- (2009) Johannes Lammer et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma
- (2009) M. MABED et al. EUROPEAN JOURNAL OF CANCER CARE
- Transarterial Injection of 131I-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer
- (2009) L. Marelli et al. JOURNAL OF NUCLEAR MEDICINE
- TACE versus TAE as therapy for hepatocellular carcinoma
- (2008) Maria Pleguezuelo et al. Expert Review of Anticancer Therapy
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial
- (2008) Franco Brunello et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started